# Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

> **NCT06242379** · PHASE1,PHASE2 · RECRUITING · sponsor: **Mahidol University** · enrollment: 15 (estimated)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **BIOLOGICAL:** GMP compliant-BM-MSC derived sEVs

## Key facts

- **NCT ID:** NCT06242379
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-23
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06242379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06242379, "Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06242379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*